Before you sell to, join or invest in Apnimed, Inc.
MentionFox check on Apnimed, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/apnimed-inc-form-d-25000002
Check Apnimed, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Apnimed, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Apnimed, Inc. filed a Form D with the Securities and Exchange Commission on 2025-04-24.
Apnimed, Inc. filed a Form D notice of an exempt securities offering with the SEC on April 24, 2025. Apnimed, Inc. trades on Nasdaq as APMD. The filing reports $16.50M sold. Its industry group is Pharmaceuticals. It names Lawrence Miller (Executive Officer, Director), Barry Wohl (Executive Officer), Dennis Molnar (Executive Officer) (SEC Form D, April 24, 2025).
In its own words: “We envision a new era where novel oral therapies simplify treatment and improve oxygenation of people living with obstructive sleep apnea.” (apnimed.com, checked November 1, 2026)
Is this your company?
Sell to companies like Apnimed, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-04-24 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Apnimed, Inc.
Free to see. No signup.
More on the people and the money behind Apnimed, Inc., from the filings we hold.
Pharmaceuticals raises by companies based in Massachusetts, filed within 90 days of this one, largest first.
Get an email when Apnimed, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Apnimed, Inc. raises, hires or launches. No email unless you switch it on.
Watch Apnimed, Inc. →Get the full cited report on Apnimed, Inc.
What the filing shows about Apnimed, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Apnimed, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Apnimed, Inc.'s address as 39 John F. Kennedy Street, 4TH Flr., Cambridge, MA 02138.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Apnimed, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Apnimed, Inc. is a registered filer with the SEC (CIK 1745648) and has filed since 2022-11-01. 8 filings are on record, the latest on 2026-03-27.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Apnimed, Inc.'s Form D of 2025-04-24 names Lawrence Miller, Barry Wohl, Dennis Molnar and 7 more as its officers, directors or promoters.
Its new offerings report $144.25M sold across 4 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
Checked away from the filing. What is below does not come from the record on sec.gov.
We envision a new era where novel oral therapies simplify treatment and improve oxygenation of people living with obstructive sleep apnea.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Lawrence Miller is named as Executive Officer and Director on the Form D that Apnimed, Inc. filed with the SEC on 24 April 2025, one of 10 people that filing names.
Barry Wohl is named as Executive Officer on the Form D that Apnimed, Inc. filed with the SEC on 24 April 2025, one of 10 people that filing names.
Dennis Molnar is named as Executive Officer on the Form D that Apnimed, Inc. filed with the SEC on 24 April 2025, one of 10 people that filing names.
Joseph Avellone is named as Director on the Form D that Apnimed, Inc. filed with the SEC on 24 April 2025, one of 10 people that filing names.
Francois Beaubien is named as Director on the Form D that Apnimed, Inc. filed with the SEC on 24 April 2025, one of 10 people that filing names.
Isaac Cheng is named as Director on the Form D that Apnimed, Inc. filed with the SEC on 24 April 2025, one of 10 people that filing names.
Chris Dimitropoulos is named as Director on the Form D that Apnimed, Inc. filed with the SEC on 24 April 2025, one of 10 people that filing names.
Paul Fonteyne is named as Director on the Form D that Apnimed, Inc. filed with the SEC on 24 April 2025, one of 10 people that filing names.
Kevin Lind is named as Director on the Form D that Apnimed, Inc. filed with the SEC on 24 April 2025, one of 10 people that filing names.
Gary Sender is named as Director on the Form D that Apnimed, Inc. filed with the SEC on 24 April 2025, one of 10 people that filing names.
10 people named on the filing — 3 holding an executive role and 7 as directors only.
Named as of the 2025-04-24 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Apnimed, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Apnimed, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Apnimed, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Apnimed, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Apnimed, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-11-04 (apnimed.com).
Each opens in a new tab, filled in for Apnimed, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/apnimed-inc-form-d-25000002